ACT Dad's Power: Feasibility RCT for Fathers of Children With Special Needs
ACT Dad's Power: A Feasibility Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Fathers of Children With Special Needs in Improving Their Psychological Flexibility and Mental Health
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
Objective: (1) To examine the feasibility of proceeding to a future definitive RCT of ACT in Hong Kong Chinese fathers rearing children with special needs. (2) To calculate the effect sizes of the intervention on fathers' psychological flexibility, shame, guilt, and quality of life (QoL) at the 6-month follow-up. (3) To calculate the potential efficacy of the intervention. Methods: A 2-arm feasibility randomised controlled trail will be conducted on 50 fathers of children with special needs. 25 participants will be allocated into the intervention group to attend 6 weekly 45-60 minute sessions of ACT with VR. 25 participants will be allocated to the control group receiving 6 weekly 45-60 minute sessions of health talks and simple social support. Outcome and measurement: Primary outcomes are screening rate, eligibility rate, consent rate, randomization rate, attendance rate, adherence rate, retention rate, completion rate, missing data, and adverse events. Secondary outcomes are the effect sizes and preliminary efficacy of the intervention on psychological flexibility, shame, guilt, depressive symptoms, and QoL at T4. Both groups will be required to fill in a set of questionnaires at the start of intervention (T1), post-intervention (T2), 3 (T3), and 6 months (T4) after the end of intervention. They will also be invited to join semi-structure interviews at T2. Data analysis: Descriptive statistics, mixed between-within-participants analysis of variance, and content analysis will be used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2026
CompletedFirst Posted
Study publicly available on registry
March 9, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2028
March 9, 2026
March 1, 2026
2.3 years
February 27, 2026
March 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Screening rate
Calculated as the number of fathers of children with special needs screened at participated NGOs divided by number of fathers with special needs at participated NGOs during the recruitment period.
During the recruitment period (up to 10 months)
Eligibility rate
Calculated by dividing the number of fathers who are eligible by the number who are screened.
During the recruitment period (up to 10 months)
Consent rate
Calculated by dividing the number of fathers who consent to join the study by the number who are eligible.
During the recruitment period (up to 10 months)
Randomization rate
Calculated by dividing the number of fathers who are randomized into intervention and control groups by those who provide consent.
T1 (start of intervention)
Attendance rate
Calculated by dividing the number of fathers who complete the intervention by those who are randomized.
T2 (post-intervention at 6 weeks)
Retention rate
Calculated by dividing the number of fathers who remain in the study by those who are randomized. Retention rates for the intervention and control groups will be calculated at each follow-up.
T2 (post-intervention at 6 weeks), T3 (3 months after intervention), T4 (6 months after intervention)
Adherence rate
Calculated by dividing the number of fathers who follow the intervention protocol by those who are randomized.
T2 (post-intervention at 6 weeks)
Complete rate
Calculated by dividing the number of fathers who returned questionnaires by the number of questionnaires distributed. This will be calculated by groups at baseline and each follow-up.
T1 (start of intervention) , T2 (post-intervention at 6 weeks), T3 (3 months after intervention), T4 (6 months after intervention)
Proportion of missing data
Calculated as the percentage of missing values in the dataset. Unknown or blank values will be considered missing values.
T4 (6 months after intervention)
Adverse events
Adverse events are defined as unfavorable and unintended events that are not present at baseline, or appear to have worsened during the study.
T4 (6 months after intervention)
Secondary Outcomes (5)
Psychological flexibility
T1 (at the start of intervention), T4 (at 6 months after the end of intervention)
Shame
T1 (at the start of intervention), T4 (at 6 months after the end of intervention)
Guilt
T1 (at the start of intervention), T4 (at 6 months after the end of intervention)
Depressive symptoms
T1 (at the start of intervention), T4 (at 6 months after the end of intervention)
Quality of life (QoL)
T1 (at the start of intervention), T4 (at 6 months after the end of intervention)
Study Arms (2)
VR-based ACT
EXPERIMENTALVR-based ACT for fathers of children with special needs
Control
PLACEBO COMPARATORhealth talks and simple social support
Interventions
Participants in the intervention group will be invited to attend 6 weekly sessions of ACT with VR. Each session will last approximately 45-60 minutes.
Participants in the control group will receive 6 weekly sessions of health talks and simple social support to mimic the time and attention spent on the intervention group.
Eligibility Criteria
You may qualify if:
- (1) who are the biological fathers of children aged 2 to 12 years
- (2) with a child having a formal diagnosis of a developmental disability, including autism spectrum disorder, attention deficit/hyperactivity disorder, intellectual disability, or related neurodevelopmental conditions
- (3) who are able to speak Cantonese and read Chinese
You may not qualify if:
- (1) who are currently undergoing psychotherapies
- (2) with physical or cognitive impairment and learning problems as identified from NGO or related medical records
- (3) who exhibit a high risk of serious mental illnesses screened using the Kessler Psychological Distress Scale , with a score of ≥13
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 27, 2026
First Posted
March 9, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
October 1, 2028
Study Completion (Estimated)
October 1, 2028
Last Updated
March 9, 2026
Record last verified: 2026-03